{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:43Z","timestamp":1753891843764,"version":"3.41.2"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:p>Hydroxychloroquine (HCQ) is a commonly used medication for its immunosuppressive and dermatologic effects. It has known ocular side effects, which include retinopathy, corneal deposits, and choroidal thinning. Herein, we report the first known case of HCQ-induced hyperpigmentation of the sclera. A 75-year-old female presented after 10 months of gradual progression of painless blue-gray discoloration of the bilateral sclera, fingernails, and lower extremities secondary to oral HCQ therapy. Cessation of the drug led to a partial reversal of the hyperpigmentation at 5\u00a0months, further supporting HCQ as the causative agent. Hyperpigmentation reactions can be distressing to patients and lead to decreased medication adherence; given the widespread use of HCQ, it is important to increase awareness of this potential drug reaction.<\/jats:p>","DOI":"10.3389\/fopht.2023.1192019","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T04:59:14Z","timestamp":1685941154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Scleral hyperpigmentation associated with oral hydroxychloroquine use"],"prefix":"10.3389","volume":"3","author":[{"given":"Caroline","family":"Maretz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Omoruyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A. F.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2019.04.180212","article-title":"Drug-induced hyperpigmentation: review and case series","volume":"32","author":"Gimenez Garcia","year":"2019","journal-title":"J Am Board Fam Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12042","article-title":"Drug-induced hperpigemntation: a systematic review","volume":"11","author":"Krause","year":"2013","journal-title":"JDDG: J der Deutschen Dermatologischen Gesellschaft"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5693\/djo.03.2010.02.002","article-title":"A 54-year-old woman with bluish discoloration of her sclera","volume":"16","author":"Phan","year":"2010","journal-title":"Digit J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","author":"Alm","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17928","article-title":"Dermatological adverse effects of anti-glaucoma eye drops: a review","volume":"36","author":"Patchinsky","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1970.00990040548029","article-title":"Epinephrine pigmentation","volume":"84","author":"Bullock","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04694-2","article-title":"Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates","volume":"40","author":"Misra","year":"2020","journal-title":"Rheumatol Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1503\/cmaj.150622","article-title":"Hydroxychloroquine-related skin discoloration","volume":"189","author":"Coulombe","year":"2017","journal-title":"CMAJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320985214","article-title":"The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients","volume":"30","author":"Pedrosa","year":"2021","journal-title":"Lupus"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-102615","article-title":"Hydroxychloroquine-induced retinal toxicity","volume":"233","author":"Iselin","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2023.1192019\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T04:59:16Z","timestamp":1685941156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2023.1192019\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":12,"alternative-id":["10.3389\/fopht.2023.1192019"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2023.1192019","relation":{},"ISSN":["2674-0826"],"issn-type":[{"type":"electronic","value":"2674-0826"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"article-number":"1192019"}}